P3.18.39 PRESERVE-003: A Phase 3 Study of Gotistobart Versus Docetaxel in Metastatic NSCLC After Progression on PD-(L)1 Inhibitors
Author:
T. Li,Y. Wu,B.C. Cho,R. Balaraman,H-J. Chen,A. Fawole,X. Yu,Z-g. Liu,J. Zhang,J. Hamm,W. Long,B. Yang,J. Leddon,Y. Huang,P. Pan,S. Shpyro,Q. Wang,P. Zheng,Y. Liu,S. Efuni,K. He,M.A. Socinski
Publication:
Journal of Thoracic Oncology
Copyright © 2025 Published by Elsevier Inc.